RAD51 and hepatocellular carcinoma: Numerous studies have demonstrated the vital oncogenic role of AURKB (30), BIRC5 (31), KIF11 (32), PLK1 (33), PLK4 (34), RAD51 (35), TOP2A (36), TTK (37), and TUBB3 (38) in various cancers, including HCC.